作者:Timo Weide、S. Adrian Saldanha、Dmitriy Minond、Timothy P. Spicer、Joseph R. Fotsing、Michael Spaargaren、Jean-Marie Frère、Carine Bebrone、K. Barry Sharpless、Peter S. Hodder、Valery V. Fokin
DOI:10.1021/ml900022q
日期:2010.7.8
Metallo-beta-lactamases (MBLs) are an emerging cause of bacterial resistance to antibiotic treatment. The VIM-2 beta-lactamase is the most commonly encountered MBLs in clinical isolates worldwide. Described here are potent and selective small molecule inhibitors of VIM-2 containing the arylsulfonyl-NH-1,2,3-triazole chemotype that potentiate the efficacy of the beta-lactam, imipenem, in Escherichia coli.